Development of the PREDS score to predict in-hospital mortality of patients with Ebola virus disease under advanced supportive care: Results from the EVISTA cohort in the Democratic Republic of the Congo

10th Ebola outbreak in the Democratic Republic of the Congo declared over; vigilance against flare-ups and support for survivors must continue.https://www.who.int/news/item/25-06-2020-10th-ebola-outbreak-in-the-democratic-republic-of-the-congo-declared-over-vigilance-against-flare-ups-and-support-for-survivors-must-continue. Accessed 21 July 2022. Henao-Restrepo, 2017, Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!), Lancet Lond Engl, 389, 505, 10.1016/S0140-6736(16)32621-6 Coller, 2017, Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic, Vaccine, 35, 4465, 10.1016/j.vaccine.2017.05.097 Mulangu, 2019, A randomized, controlled trial of Ebola virus disease therapeutics, N Engl J Med, 381, 2293, 10.1056/NEJMoa1910993 Fischer, 2019, Shifting the paradigm - applying universal standards of care to ebola virus disease, N Engl J Med, 380, 1389, 10.1056/NEJMp1817070 Lamontagne, 2018, Evidence-based guidelines for supportive care of patients with Ebola virus disease, Lancet Lond Engl, 391, 700, 10.1016/S0140-6736(17)31795-6 Leligdowicz, 2016, Ebola virus disease and critical illness, Crit Care Lond Engl, 20, 217, 10.1186/s13054-016-1325-2 Langer, 2018, Intensive care support and clinical outcomes of patients with Ebola virus disease (EVD) in West Africa, Intensive Care Med, 44, 1266, 10.1007/s00134-018-5308-4 Fowler, 2014, Caring for critically ill patients with ebola virus disease. Perspectives from West Africa, Am J Respir Crit Care Med, 190, 733, 10.1164/rccm.201408-1514CP Lamontagne, 2014, Doing today's work superbly well–treating Ebola with current tools, N Engl J Med, 371, 1565, 10.1056/NEJMp1411310 Optimized supportive care for Ebola virus disease.https://www.who.int/publications-detail/optimized-supportive-care-for-ebola-virus-disease. Accessed 6 January 2020. National Early Warning Score (NEWS) 2. RCP Lond. 2017; published online Dec 19. https://www.rcplondon.ac.uk/projects/outputs/national-early-warning-score-news-2. Accessed 17 September 2021. Lamontagne, 2019, The evolution of supportive care for Ebola virus disease, Lancet Lond Engl, 393, 620, 10.1016/S0140-6736(19)30242-9 Malvy, 2019, Ebola virus disease, Lancet Lond Engl, 393, 936, 10.1016/S0140-6736(18)33132-5 Sullivan, 2004, Presentation of multivariate data for clinical use: the Framingham study risk score functions, Stat Med, 23, 1631, 10.1002/sim.1742 Buuren, 2011, MICE: multivariate imputation by chained equations in R, J Stat Softw, 45, 10.18637/jss.v045.i03 Marshall, 2010, Comparison of imputation methods for handling missing covariate data when fitting a Cox proportional hazards model: a resampling study, BMC Med Res Methodol, 10, 112, 10.1186/1471-2288-10-112 Jacob, 2020, Ebola virus disease, Nat Rev Dis Primer, 6, 13, 10.1038/s41572-020-0147-3 Bah, 2015, Clinical presentation of patients with Ebola virus disease in Conakry, Guinea, N Engl J Med, 372, 40, 10.1056/NEJMoa1411249 Mobula, 2018, Clinical manifestations and modes of death among patients with Ebola virus disease, Monrovia, Liberia, 2014, Am J Trop Med Hyg, 98, 1186, 10.4269/ajtmh.17-0090 Schieffelin, 2014, Clinical illness and outcomes in patients with Ebola in Sierra Leone, N Engl J Med, 371, 2092, 10.1056/NEJMoa1411680 Lado, 2015, Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study, Lancet Infect Dis, 15, 1024, 10.1016/S1473-3099(15)00137-1 van Griensven, 2016, Electrolyte and metabolic disturbances in Ebola patients during a clinical trial, Guinea, 2015, Emerg Infect Dis, 22, 10.3201/eid2212.161136 Hunt, 2015, Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study, Lancet Infect Dis, 15, 1292, 10.1016/S1473-3099(15)00144-9 Loignon, 2018, Barriers to supportive care during the Ebola virus disease outbreak in West Africa: results of a qualitative study, PloS One, 13, 10.1371/journal.pone.0201091 Iversen, 2020, Recent successes in therapeutics for Ebola virus disease: no time for complacency, Lancet Infect Dis, 20, e231, 10.1016/S1473-3099(20)30282-6 Uyeki, 2016, Clinical Management of Ebola virus disease in the United States and Europe, N Engl J Med, 374, 636, 10.1056/NEJMoa1504874 Kangbai, 2020, Severity score for predicting in-facility Ebola treatment outcome, Ann Epidemiol, 49, 68, 10.1016/j.annepidem.2020.07.017 Hartley, 2017, Predicting Ebola severity: a clinical prioritization score for Ebola virus disease, PLoS Negl Trop Dis, 11 Duvignaud, 2021, Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study, Lancet Glob Health, 9, e469, 10.1016/S2214-109X(20)30518-0